FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211370747> ?p ?o ?g. }

• W3211370747 endingPage "17" @default.
• W3211370747 startingPage "12" @default.
• W3211370747 abstract "As disease control and quality of life play a leading role in metastatic breast cancer (MBC), metronomic chemotherapy (MCT) is gaining popularity alongside conventional chemotherapy (CCT) and targeted therapies.MCT, defined as continuous administration of low-dose chemotherapeutic agents, is accepted as a therapy that exerts its effects via immunomodulation, anti-angiogenesis and direct cytotoxic effects. Oral administration of MCT is safe, easy to handle, and allows for flexible drug dosing. Dose accumulations associated with non-tolerable side effects are rare, so the medication can be administered for longer periods of time. Patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic disease resistant to endocrine-based therapy and not requiring rapid tumor response are generally suitable for MCT. However, MCT may also be promising in patients with triple-negative and HER2-positive tumors without aggressive disease who prefer a lower toxicity profile compared to CCT. The most commonly used agents are cyclophosphamide (CTX), methotrexate (MTX), capecitabine (CAPE), and vinorelbine (VRL), whereby a combination of agents is frequently applied. Key Messages: Based on the growing body of evidence, MCT can be considered as a suitable treatment option in selected MBC patients. Nevertheless, there is an urgent need for randomized controlled trials comparing MCT with CCT, but also with best supportive care. Due to the multimodal mechanisms of action, the combination with targeted and immunological therapies may represent a new promising approach for the treatment of MBC." @default.
• W3211370747 created "2021-11-22" @default.
• W3211370747 creator A5008883508 @default.
• W3211370747 creator A5054540648 @default.
• W3211370747 creator A5059885667 @default.
• W3211370747 creator A5060699967 @default.
• W3211370747 date "2021-11-18" @default.
• W3211370747 modified "2023-10-17" @default.
• W3211370747 title "Metronomic Chemotherapy for Metastatic Breast Cancer" @default.
• W3211370747 cites W1984750597 @default.
• W3211370747 cites W2012881761 @default.
• W3211370747 cites W2021399951 @default.
• W3211370747 cites W2030646983 @default.
• W3211370747 cites W2032303062 @default.
• W3211370747 cites W2034185054 @default.
• W3211370747 cites W2059294866 @default.
• W3211370747 cites W2061444118 @default.
• W3211370747 cites W2066204710 @default.
• W3211370747 cites W2102392974 @default.
• W3211370747 cites W2104316189 @default.
• W3211370747 cites W2116504531 @default.
• W3211370747 cites W2147468938 @default.
• W3211370747 cites W2151576046 @default.
• W3211370747 cites W2164653269 @default.
• W3211370747 cites W2169965478 @default.
• W3211370747 cites W2277706221 @default.
• W3211370747 cites W2309983655 @default.
• W3211370747 cites W2509111028 @default.
• W3211370747 cites W2531871678 @default.
• W3211370747 cites W2538410666 @default.
• W3211370747 cites W2580198055 @default.
• W3211370747 cites W2751119678 @default.
• W3211370747 cites W2772888620 @default.
• W3211370747 cites W2786853294 @default.
• W3211370747 cites W2800488493 @default.
• W3211370747 cites W2800764403 @default.
• W3211370747 cites W2807441606 @default.
• W3211370747 cites W2898318956 @default.
• W3211370747 cites W2907518195 @default.
• W3211370747 cites W2969746669 @default.
• W3211370747 cites W2979291688 @default.
• W3211370747 cites W3005893653 @default.
• W3211370747 cites W3031922078 @default.
• W3211370747 cites W3033638597 @default.
• W3211370747 cites W3042238380 @default.
• W3211370747 cites W3109199934 @default.
• W3211370747 cites W3128646645 @default.
• W3211370747 cites W3157851117 @default.
• W3211370747 cites W3185497325 @default.
• W3211370747 cites W3202606573 @default.
• W3211370747 cites W4206666777 @default.
• W3211370747 cites W4211032970 @default.
• W3211370747 doi "https://doi.org/10.1159/000520236" @default.
• W3211370747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34794154" @default.
• W3211370747 hasPublicationYear "2021" @default.
• W3211370747 type Work @default.
• W3211370747 sameAs 3211370747 @default.
• W3211370747 citedByCount "9" @default.
• W3211370747 countsByYear W32113707472022 @default.
• W3211370747 countsByYear W32113707472023 @default.
• W3211370747 crossrefType "journal-article" @default.
• W3211370747 hasAuthorship W3211370747A5008883508 @default.
• W3211370747 hasAuthorship W3211370747A5054540648 @default.
• W3211370747 hasAuthorship W3211370747A5059885667 @default.
• W3211370747 hasAuthorship W3211370747A5060699967 @default.
• W3211370747 hasConcept C121608353 @default.
• W3211370747 hasConcept C126322002 @default.
• W3211370747 hasConcept C143998085 @default.
• W3211370747 hasConcept C2775930923 @default.
• W3211370747 hasConcept C2776694085 @default.
• W3211370747 hasConcept C2776755627 @default.
• W3211370747 hasConcept C2777909004 @default.
• W3211370747 hasConcept C2778239845 @default.
• W3211370747 hasConcept C2780350996 @default.
• W3211370747 hasConcept C526805850 @default.
• W3211370747 hasConcept C530470458 @default.
• W3211370747 hasConcept C71924100 @default.
• W3211370747 hasConcept C98274493 @default.
• W3211370747 hasConceptScore W3211370747C121608353 @default.
• W3211370747 hasConceptScore W3211370747C126322002 @default.
• W3211370747 hasConceptScore W3211370747C143998085 @default.
• W3211370747 hasConceptScore W3211370747C2775930923 @default.
• W3211370747 hasConceptScore W3211370747C2776694085 @default.
• W3211370747 hasConceptScore W3211370747C2776755627 @default.
• W3211370747 hasConceptScore W3211370747C2777909004 @default.
• W3211370747 hasConceptScore W3211370747C2778239845 @default.
• W3211370747 hasConceptScore W3211370747C2780350996 @default.
• W3211370747 hasConceptScore W3211370747C526805850 @default.
• W3211370747 hasConceptScore W3211370747C530470458 @default.
• W3211370747 hasConceptScore W3211370747C71924100 @default.
• W3211370747 hasConceptScore W3211370747C98274493 @default.
• W3211370747 hasIssue "1-2" @default.
• W3211370747 hasLocation W32113707471 @default.
• W3211370747 hasLocation W32113707472 @default.
• W3211370747 hasOpenAccess W3211370747 @default.
• W3211370747 hasPrimaryLocation W32113707471 @default.
• W3211370747 hasRelatedWork W2027544639 @default.
• W3211370747 hasRelatedWork W2213973060 @default.

• next